The Morning Dispatch: What’s the Deal With Hydroxychloroquine?

Happy Monday. At least in D.C., we’re now squarely in the thick of spring allergy season. Not ideal when incessantly on high alert for any respiratory symptoms.

Quick Hits: Today’s Top Stories

  • As of Sunday night, there are now 337,620 confirmed cases of COVID-19 in the United States (a 37.7 percent increase from Thursday night) and 9,643 deaths (a 61.2 percent increase from Thursday night), according to the Johns Hopkins University COVID-19 Dashboard, leading to a mortality rate among confirmed cases of 2.9 percent (the true mortality rate is difficult to calculate due to incomplete testing regimens). Of 1,762,032 coronavirus tests conducted in the United States, 18.9 percent have come back positive, per the COVID Tracking Project, a separate dataset with slightly different topline numbers.

  • The Supreme Court canceled oral arguments for the nine cases it was scheduled to hear the rest of this term. The justices are still doing business relating to cases they’ve already heard, and are exploring alternatives to hearing cases in person.

  • President Trump fired Michael Atkinson—the intelligence community inspector general—late Friday night. Atkinson had flagged the Ukraine whistleblower’s complaint last fall. He released a remarkable statement about his dismissal on Sunday.

This content is available exclusively to Dispatch members
Try a membership for full access to every newsletter and all of The Dispatch. Support quality, fact-based journalism.
Already a paid member? Sign In
Comments (0)
Join The Dispatch to participate in the comments.

There are currently no responses to this article.
Be the first to respond.